ACTA1 and systemic sclerosis: Consistent with the presence of antifibrotic factors in SSc-ASC, such as HGF, TIMP-1, and MMP-2, we found that these cells reduced αSMA expression levels and collagen content in DF from SSc patients, demonstrating significant antifibrotic paracrine effects in vitro.